GlucoTrack EPS - Earnings per Share 2011-2025 | GCTK
GlucoTrack eps - earnings per share from 2011 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| GlucoTrack Annual EPS | |
|---|---|
| 2024 | $-4,098.20 |
| 2023 | $-2,046.71 |
| 2022 | $-1,736.53 |
| 2021 | $-1,556.89 |
| 2020 | $-1,137.72 |
| 2019 | $-1,557.35 |
| 2018 | $-369,092.80 |
| 2017 | $-145,612.50 |
| 2016 | $-84,097.09 |
| 2015 | $-89,547.82 |
| 2014 | $28,811.04 |
| 2013 | $-151,842.00 |
| 2012 | $-40,491.19 |
| 2011 | $35,819.13 |
| 2010 | $54,507.37 |
| GlucoTrack Quarterly EPS | |
|---|---|
| 2025-03-31 | $-40.12 |
| 2024-12-31 | $-1,323.95 |
| 2024-09-30 | $-1,089.82 |
| 2024-06-30 | $-982.04 |
| 2024-03-31 | $-702.40 |
| 2023-12-31 | $-657.49 |
| 2023-09-30 | $-586.83 |
| 2023-06-30 | $-323.35 |
| 2023-03-31 | $-479.04 |
| 2022-12-31 | $-538.92 |
| 2022-09-30 | $-359.28 |
| 2022-06-30 | $-419.16 |
| 2022-03-31 | $-419.16 |
| 2021-12-31 | $-538.92 |
| 2021-09-30 | $-299.40 |
| 2021-06-30 | $-359.28 |
| 2021-03-31 | $-359.28 |
| 2020-12-31 | $-718.56 |
| 2020-09-30 | $-179.64 |
| 2020-06-30 | $-239.52 |
| 2020-03-31 | $0.00 |
| 2019-12-31 | $778.68 |
| 2019-09-30 | $-778.68 |
| 2019-06-30 | $-778.68 |
| 2019-03-31 | $-778.68 |
| 2018-12-31 | $-292,782.40 |
| 2018-09-30 | $-24,138.98 |
| 2018-06-30 | $-25,696.33 |
| 2018-03-31 | $-26,475.01 |
| 2017-12-31 | $-36,597.80 |
| 2017-09-30 | $-34,261.78 |
| 2017-06-30 | $-37,376.48 |
| 2017-03-31 | $-37,376.48 |
| 2016-12-31 | $-18,688.24 |
| 2016-09-30 | $-23,360.30 |
| 2016-06-30 | $-23,360.30 |
| 2016-03-31 | $-18,688.24 |
| 2015-12-31 | $-22,581.62 |
| 2015-09-30 | $-17,130.89 |
| 2015-06-30 | $-25,696.33 |
| 2015-03-31 | $-24,138.98 |
| 2014-12-31 | $-7,008.09 |
| 2014-09-30 | $-12,458.83 |
| 2014-06-30 | $60,736.78 |
| 2014-03-31 | $-12,458.83 |
| 2013-12-31 | $-109,793.40 |
| 2013-09-30 | $-12,458.83 |
| 2013-06-30 | $-10,122.80 |
| 2013-03-31 | $-19,466.92 |
| 2012-12-31 | $0.00 |
| 2011-12-31 | $0.00 |
| 2010-12-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.003B | $0.000B |
| GlucoTrack Inc. is an innovator of GlucoTrack(R), a non-invasive device and digital health platform for measuring glucose levels in people with Type 2 diabetes and prediabetes. GlucoTrack Inc., formerly known as Integrity Applications Inc., is based in Rutherford, NJ. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $209.668B | 24.59 |
| Boston Scientific (BSX) | United States | $154.824B | 38.76 |
| Stryker (SYK) | United States | $148.439B | 31.04 |
| EssilorLuxottica (ESLOY) | France | $131.494B | 0.00 |
| Medtronic (MDT) | Ireland | $114.826B | 16.28 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.743B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.081B | 24.59 |
| ResMed (RMD) | United States | $37.598B | 28.24 |
| GE HealthCare Technologies (GEHC) | United States | $34.909B | 16.57 |
| Agilent Technologies (A) | United States | $33.054B | 21.55 |
| Terumo (TRUMY) | Japan | $24.345B | 31.62 |
| Koninklijke Philips (PHG) | Netherlands | $23.697B | 16.63 |
| Insulet (PODD) | United States | $19.948B | 78.30 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.776B | 12.06 |
| Baxter (BAX) | United States | $14.312B | 10.69 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.087B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.794B | 23.64 |
| Lantheus Holdings (LNTH) | United States | $5.092B | 12.85 |
| Perrigo (PRGO) | Ireland | $3.733B | 9.46 |
| Prestige Consumer Healthcare (PBH) | United States | $3.713B | 16.58 |
| Haemonetics (HAE) | United States | $3.529B | 16.07 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.347B | 27.82 |
| ICU Medical (ICUI) | United States | $3.070B | 22.64 |
| LeMaitre Vascular (LMAT) | United States | $1.855B | 41.47 |
| QuidelOrtho (QDEL) | United States | $1.804B | 12.41 |
| AtriCure (ATRC) | United States | $1.473B | 0.00 |
| Acuren (TIC) | United States | $1.444B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.242B | 12.60 |
| Green Thumb Industries (GTBIF) | United States | $1.207B | 27.14 |
| Phibro Animal Health (PAHC) | United States | $1.205B | 15.40 |
| Neogen (NEOG) | United States | $1.055B | 13.50 |
| BioLife Solutions (BLFS) | United States | $1.025B | 0.00 |
| InMode (INMD) | Israel | $0.891B | 8.98 |
| Kestra Medical Technologies (KMTS) | United States | $0.845B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.674B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.639B | 0.00 |
| Owens & Minor (OMI) | United States | $0.617B | 5.12 |
| Tilray Brands (TLRY) | Canada | $0.615B | 0.00 |
| Evolus (EOLS) | United States | $0.602B | 0.00 |
| CeriBell (CBLL) | United States | $0.565B | 0.00 |
| Valneva SE (VALN) | France | $0.553B | 0.00 |
| Surmodics (SRDX) | United States | $0.438B | 0.00 |
| SNDL (SNDL) | Canada | $0.410B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.327B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.323B | 11.89 |
| Sanuwave Health (SNWV) | United States | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.270B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.23 |
| Cerus (CERS) | United States | $0.262B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.256B | 75.83 |
| OraSure Technologies (OSUR) | United States | $0.245B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.244B | 0.00 |
| ZimVie (ZIMV) | United States | $0.241B | 10.96 |
| Biote (BTMD) | United States | $0.228B | 6.42 |
| Brainsway (BWAY) | Israel | $0.219B | 58.05 |
| Verano Holdings (VRNOF) | United States | $0.204B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.204B | 0.00 |
| Omeros (OMER) | United States | $0.204B | 0.00 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Organigram Global (OGI) | Canada | $0.196B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.82 |
| TriSalus Life Sciences (TLSI) | United States | $0.179B | 0.00 |
| Exagen (XGN) | United States | $0.153B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.125B | 15.33 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| Jin Medical (ZJYL) | China | $0.101B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.74 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Veru (VERU) | United States | $0.090B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.071B | 0.00 | |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.062B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.052B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 14.54 |
| Nephros (NEPH) | United States | $0.038B | 51.14 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |